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Abstract 
Background. Metabolic and hormonal disturbances are associated with sleep disturbances and delayed onset of lactogenesis II. 
Research Aims. The aim of this study was to measure sleep using wrist actigraphy during gestation weeks 22 and 32 to 
determine if sleep characteristics were associated with blood glucose, body mass index, gestational related disease, delayed 
onset of lactogenesis II, or work schedule. 
Methods. Demographic data were collected at study intake from primiparous women who wore a wrist actigraph during 
gestation weeks 22 (n = SO) and 32 (n = 44). Start and end sleep time, total nighttime sleep, sleep efficiency, wake after 
sleep onset, and sleep fragmentation were measured. Night to night variability was assessed with the root mean square of 
successive difference. Blood glucose levels, body mass index, and gestational disease data were abstracted from medical 
charts. Timing of lactogenesis II was determined by survey. 
Results. Between gestation week 22 and 32, sleep efficiency decreased and fragmentation increased (p < .05). During 
gestation week 32, blood glucose was negatively correlated with sleep duration, and positively related to fragmentation 
(p < .OS). Women who experienced delayed lactogenesis II had lower sleep efficiency and greater fragmentation (p < .05), 
and greater night-to-night variability in sleep start and end time, efficiency, and duration during gestation week 32 (p < .OS). 
Conclusion. Women with better sleep efficiency and more stable nightly sleep time are less likely to experience delayed 
onset of lactogenesis II. Interventions to improve sleep may improve maternal health and breastfeeding adequacy. 
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Methods 
Design 
A prospective, longitudinal, one-group observational study 
was used as it suggests relationships, and reliable inferences. 
Thus, it allowed the analysis of sleep patterns of participants 
throughout pregnancy, and the analysis of relationships 
between sleep variables and the risk of gestational diseases 
and delayed lactogenesis II ( LoBiondo-Wood & Haber, 
2014). The study was approved by Institutional Review 
Boards (!RB) at Purdue University, Indiana University , and 
Eskenazi Health. 
Setting 
The study was conducted in Indianapolis, IN, an urban area 
in the Midwest, which is the sixteenth most populous city in 
the US. Indianapolis has an estimated population of 863,002 
with the greater metropolitan area having a little over two 
million residents. The ethnic and racial mix of the population 
served by the prenatal clinic from which participants were 
recruited was approximately 35% Hispanic, 30% African­
American, 30% Caucasian, and 5% other. All data were col­
lected from participants from August 2014 to October 2015. 
Sample 
Participants were recruited from an Indiana University 
affiliated prenatal clinic that has a mission to serve the 
underserved population. Inclusion criteria were primipar­
ity, 18-40 years of age, expecting a single infant, and will­
ingness to breastfeed. There were no exclusion criteria. 
Ninety-two women were recruited for the study with the 
assumption of ~60% retention rate for a target of 50 women. 
Rationale for sample size was based on a priori power cal­
culation. Data from a study by Herring et al. (2014) was 
used to calculate the power in detecting differences in sleep 
duration between women with and without hyperglycemia. 
A power of 89%, with the alpha error rate set at 5%, was 
found for a sample size of 50. 
Measurements 
Data collected were discrete variables on participant demo­
graphics, work schedule, disease diagnosis, and self-scores 
of changes in breast fullness from time of parturition. 
Continuous variable data collected were blood glucose lev­
els, body mass index (BM!), and actigraphic measures of 
rest-activity. 
Demographic data (e.g. participant's age, education, 
ethnicity, race, occupation, and work schedule) were col­
lected at study intake, using a 24-question survey. Consent 
was obtained from women to collect protected health 
information (PHI) from medical records, which included 
data on physiological variables ( e.g. pre-pregnancy BM!, 
3 
blood glucose levels after 50g glucose challenge test and 
diagnosis of hypertension, preeclampsia, and GDM during 
pregnancy). The diagnosis of gestational related disease 
was defined according to the American Congress of 
Obstetrics and Gynecologists (ACOG) guidelines. The 50g 
glucose challenge test had been performed between 24-28 
weeks pregnancy according to the ACOG guidelines 
(ACOG, 2018). 
Actigraphic data were collected in 30-sec epochs and 
Actiware sofrware (Version 5.04; Respironics, Inc.) algo­
rithms were used to estimate sleep parameters. Researchers 
determined the nightly rest intervals by using a combina­
tion of event markers on actigrams set by the participant to 
indicate start and end of nightly rest, light exposure data 
collected by Actiwatch, and activity levels recorded on the 
actogram. Researchers verified nightly rest intervals 
against the time recorded in the participants' sleep logs 
(Patel et al., 2015). 
Sleep variables measured were: (1) the night-by-night 
actigraphic estimates of sleep onset time (start sleep time­
clock time of the first epoch scored as sleep in each rest 
interval), (2) end sleep time ( clock time of the last epoch 
scored as sleep in each rest interval), (3) total sleep time 
(TST-number of minutes scored as sleep in each rest inter­
val) and ( 4) sleep efficiency (SE-proportion of time from 
sleep onset to wake in each rest interval, scored as sleep, 
expressed as a percentage). The time in minutes of wakeful­
ness after sleep onset during the night (WASO) and frag­
mentation index (Fragl) were calculated. Fragl-the sum of 
time awake related to total sleep time and the percentage of 
very short sleep periods (cs; 15 s) related to the total number 
of sleep periods. Therefore, this index represents restless 
sleep. Sleep measures were averaged across all available 
days of recording for each period (up to 7 days). Changes in 
the sleep variables across 24 hr periods were assessed using 
the root mean square of successive difference (RMSSD; 
Burgess, Park, Wyatt, Rizvydeen & Fogg, 2017; Straus, 
Drummond, Nappi, Jenkins & Norman, 2015). RMSSD is a time-domain tool commonly used to assess heart rate vari­
ability (variability of heart rhythms), and by extension is 
used as a method to assess sleep (Bei, Wiley, Trinder & 
Manber, 2016). 
The self-report breast fullness survey was used, and is a 
validated-method that indirectly measures the timing of 
onset of lactogenesis II by maternal perception of changes in 
breast fullness in the post-partum (Perez-Escamilla & 
Chapman, 2001 ). The survey asks women to report breast 
fullness on a 1 to 5 scale, ( e.g. I = no change since giving 
birth, 3 = noticeably fuller, and 5 = uncomfortably full, and 
2 or 4 intermediate to respective order). DLII was defined as 
not reporting, at least, 'noticeably fuller' breasts (i.e. having 
a score of< 3) by day 3 post-partum (Dewey et al., 2003; 
Nommsen-Rivers et al., 2010). This is criteria set forth by 
Chapman and Perez-Escamilla (2001) for determining if 
milk has come in (lactogenesis II has commenced). 
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Table I. Demographic and Health Characteristics of Study 
Sample (n=42). 
Characteristics 
Race 
African American 
White 
More than one race, or other 
Unknown/not reported 
Ethnicity 
Hispanic 
not Hispanic or Latino 
Education 
Graduate degree 
Bachelor degree 
Associate degree 
High school or GED 
No high school or GED 
Yearly household income 
Less than $10,000 
2'$10,000, but <$25,000 
2'$25,000, but <$50,000 
2'$50,000 
Diagnosis 
Pre-eclampsia 
GDM 
Hypertension 
Any gestational diseasea 
BMI >25 
Hyperglycemia (blood glucose ee 130 mg/dl) 
n (%) 
27 (64) 
7 (18) 
5 (13) 
3 (5) 
6 (14) 
36 (86) 
6 (14) 
5 (I I) 
3 (7) 
26 (64) 
2 (4) 
19 (45) 
IO (23) 
10 (23) 
4 (9) 
5 (11) 
4 (9) 
21 (25) 
14 (33) 
20 (48) 
7 (16) 
Note. Data presented describe the demographics and rate of diagnosis 
among the 46% of participants (n=42) who completed all aspects of the 
study. The total sample size was N=92. 
aAny gestational disease is percent of population with any diagnosis of 
preeclampsia, hypertension, and/or gestational diabetes mellitus (GDM); 
therefore percent not additive across diagnosis, BMI= Body mass index. 
populations found no difference in demographic variables 
among groups. 
Relationships Between Gestational Week, Sleep 
and Activity Variables 
The mean number of days of recorded actigraphic data 
were 6.5 (0.8) days at gestational week 22 and 6.6 (0.8) 
days at gestational week 32, with minimum number of 
recorded days at 3.5 and 4, respectively. There was no dif­
ference between mean total night sleep time for gestational 
week 22 (7.35 (1.18) hr/night) and gestational week 32 
(7.13 (1.06) hr/night; Table 2). However, sleep efficiency 
was significantly decreased between gestational week 22 
and gestational week 32, while WASO and Fragl signifi­
cantly increased, indicating that sleep continuity decreased 
between the second and third trimester. There were no sig­
nificant differences in RMSSD, suggesting there was no 
change in night-to-night variability in the sleep measures 
between gestational time points. 
Table 2. Comparison of Sleep Variables M easured by Wrist 
Actigraphy during Gestational Week 22 and 32a. 
Start sleep time 
End sleep time 
Total sleep time (min) 
Sleep efficiency (%/ 
WASO (min)' 
Gestational 
Week 22 
n=50 
M (SD) 
00:20 ( I. 9) 
06:48 (3.6) 
441 (71) 
88 (4) 
61 (25) 
Gestational 
Week32 
n=44 
M (SD) 
00:20 (1.9) 
07:30 ( 2.7) 
424 (62) 
86 (6.5) 
73 (36) 
p 
0.07 0.67 
0.20 0.19 
0.14 0.39 
0.39 0.01 
0.37 0.02 
5 
Fragl' 21.6 (6.2) 24.9 (8.4) 0.49 0.001 
"based on Wilcoxon rank sum test 
bSleep efficiency is the proportion of time from sleep onset to wake in 
each rest interval, scored as sleep, expressed as a percentage. 
WASO is wake after sleep onset. 
dFragl is fragmentation index, which is the sum of time awake related to total 
sleep time and the percentage of very short sleep periods (::51 Ss) related to 
the total number of sleep periods, and therefore is an index of restless sleep. 
Table 3. Correlation of Blood Glucose Levels with Sleep 
Variables During Gestational Weeks 22 and 32. 
Gestational week 22 Gestational week 32 
n=50 n=44 
mean r p r p 
Start sleep time -0.15 0.35 0.10 0.53 
End sleep time -0.02 0.90 -0.10 0.56 
Total sleep time 0.01 0.95 -0.37 0.02 
Sleep efficiencl -0.13 0.41 -0.21 0.19 
WAso• 0.13 0.41 0.13 0.43 
Fraglc 0.18 0.26 0.42 0.01 
"Sleep efficiency is the proportion of time from sleep onset to wake in 
each rest interval, scored as sleep, expressed as a percentage. 
bWASO is wake after sleep onset. 
�Fragl is fragmentation index, which is the sum of time awake related to 
total sleep time and the percentage of very short sleep periods (:::S 15 s) 
related to the total number of sleep periods, and therefore is an index of 
restless sleep. 
Relationship of Sleep and Activity With Health 
Indicators 
Approximately 16% (n = 30) of the participants had hyper­
glycemia (;e, 130 mg/dL). Linear regression analysis showed 
no significant relationship between actigraphic mean or 
RMS SD of sleep measures at gestational week 22 with blood 
glucose levels (Table 3). Blood glucose levels were nega­
tively associated with total sleep duration (time) and posi­
tively associated with Fragl at gestational' week 32. 
Approximately 48% (n = 24) of the participants had 
healthy pre-pregnancy BM! (> 18.5, <25), 4% (11 = 2) 
were underweight (BM! < 18.5), 20% (n = 10) were 







